Browsing by Author López López, Carlos
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 26-Feb-2015 | A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features | Salazar Soler, Ramón; Capdevila, Jaume; Laquente, Berta; Manzano, José Luis; Pericay, Carles; Martínez Villacampa, Mercedes; López López, Carlos; Losa Gaspà, Ferran; Safont, María José; Gómez, Auxiliadora; Alonso, Vicente; Escudero, Pilar; Gallego, Javier; Sastre, Javier; Grávalos, Cristina; Biondo, Sebastián; Palacios, Amalia; Aranda, Enrique |
| 31-May-2002 | Factor de transcripción ACII ("Activator of Class II"), El. Formas proteicas, estructura y unión al ADN. | López López, Carlos |
| 1-Feb-2025 | Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study | Olmo García, María Isabel del; Hernández Rienda, Lorena; Garcia Carbonero, Rocio; Hernando, Jorge; Custodio, Ana; Anton Pascual, Beatriz; Gómez, Marta; Palma Milla, Samara; Suarez, Lorena; Bellver, Marta; Alonso, Vicente; Serrano, Raquel; Valdés, Nuria; Melián, Marcos; Febrero, Beatriz; Sampedro Nuñez, Miguel Antonio; Biarnes, Josefina; Díaz Pérez, José Ángel; Molina Cerrillo, Javier; López López, Carlos; Martínez Olmos, Miguel Ángel; Merino Torres, Juan Francisco; Capdevila, Jaume; Argente Pla, María; Nutrigetne Group |
| 1-May-2019 | Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial | Santos, Cristina; Azuara García, Daniel; Viéitez, J. M.; Páez, D.; Falcó, E.; Élez, Elena; López López, Carlos; Valladares, M.; Robles Díaz, L.; García Alfonso, Pilar; Bugés, C.; Durán, G.; Salud, A.; Navarro, V.; Capellá, G. (Gabriel); Aranda, Enrique; Salazar Soler, Ramón; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
| 30-Sep-2019 | The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC) | Bendell, Johanna C.; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López López, Carlos; García Alfonso, Pilar; Hussein, Maen; Limon Miron, Maria Luisa; Cervantes, Andrés; Montagut Viladot, Clara; Santos, Cristina; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Bennouna, Jaafar; Westhuizen, Andre; Samuel, Leslie; Rossomanno, Simona; Boetsch, Christophe; Lahr, Angelika; Franjkovic, Izolda; Heil, Florian; Lechner, Katharina; Krieter, Oliver; Hurwitz, Herbert; McCAVE Study Group |